PUBLICATIONS · 22302783
Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2012 Nov
- First author
- Rapkin L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Rapkin L
- type
- Author
- name
- Qayed M
- type
- Author
- name
- Brill P
- type
- Author
- name
- Martin M
- type
- Author
- name
- Clark D
- type
- Author
- name
- George BA
- type
- Author
- name
- Olson TA
- type
- Author
- name
- Wasilewski-Masker K
- type
- Author
- name
- Alazraki A
- type
- Author
- name
- Katzenstein HM
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Rapkin L
- type
- Author
- name
- Qayed M
- type
- Author
- name
- Brill P
- type
- Author
- name
- Martin M
- type
- Author
- name
- Clark D
- type
- Author
- name
- George BA
- type
- Author
- name
- Olson TA
- type
- Author
- name
- Wasilewski-Masker K
- type
- Author
- name
- Alazraki A
- type
- Author
- name
- Katzenstein HM
- type
- Author
- bibliography ids
- nci-bib-d01a8a5bfbf6d1b8c7fad12a
- book metadata
- content sha256
- bb9fa695da3eece8153697f29d71046e3bb5fc2a8b85bf22c35b455537bdf1ea
- document type
- citation
- dois
- 10.1002/pbc.24101
- electronic publication date
- display
- 2012 Feb 2
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22302783
- immutable id
- pubmed:22302783@bb9fa695da3eece8153697f29d71046e3bb5fc2a8b85bf22c35b455537bdf1ea
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 5
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 854-8
- volume
- 59
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22302783
- provenance
- batch id
- b6284687e167e7da9556
- provider
- NCBI PubMed ESummary
- record sha256
- 8b1a1175290bee8aa8d46edf7b787ca34dca8ad978da1e52d598c207f85aeb85
- response sha256
- 64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
- retrieved at
- 2026-09-09T23:46:45.216259+00:00
- publication date
- display
- 2012 Nov
- precision
- month
- year
- 2012
- publication types
- Clinical Trial
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas.
Preserved source evidence · Not medical advice
Triangle